Low plasma hyaluronan is associated with faster functional decline in patients with amyotrophic lateral sclerosis.

Holdom, Cory J; Ngo, Shyuan T; McCombe, Pamela A; Henderson, Robert D; Steyn, Frederik J

Holdom, Cory J; Ngo, Shyuan T; McCombe, Pamela A; Henderson, Robert D; Steyn, Frederik J.

Afiliação

Holdom CJ; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia.
Ngo ST; Centre for Clinical Research, The University of Queensland, Brisbane, Australia.
McCombe PA; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Australia.
Henderson RD; Centre for Clinical Research, The University of Queensland, Brisbane, Australia.
Steyn FJ; Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Australia, and.

Amyotroph Lateral Scler Frontotemporal Degener ; 23(1-2): 42-48, 2022 02.

Article em En | MEDLINE | ID: mdl-34569358

Assuntos

Esclerose Lateral Amiotrófica; Progressão da Doença; Humanos; Ácido Hialurônico; Estudos Longitudinais; Prognóstico

Palavras-chave

Amyotrophic lateral sclerosis; hyaluronan; rate of disease progression

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Lateral Amiotrófica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Amyotroph Lateral Scler Frontotemporal Degener Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Austrália País de publicação: Reino Unido

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google